Copyright © 2007 Elsevier Inc. All rights reserved.
d-Glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K
Received 26 June 2007.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
Although d-glucosamine has been reported as an inhibitor of tumor growth both in vivo and in vitro, the mechanism for the anticancer effect of d-glucosamine is still unclear. Since there are several reports suggesting d-glucosamine inhibits protein synthesis, we examined whether d-glucosamine affects p70S6 K activity, an important signaling molecule involved in protein translation. In the present study, we found d-glucosamine inhibited the activity of p70S6K and the proliferation of DU145 prostate cancer cells and MDA-MB-231 breast cancer cells. d-Glucosamine decreased phosphorylation of p70S6K, and its downstream substrates RPS6, and eIF-4B, but not mTOR and 4EBP1 in DU145 cells, suggesting that d-glucosamine induced inhibition of p70S6K is not through the inhibition of mTOR. In addition, d-glucosamine enhanced the growth inhibitory effects of rapamycin, a specific inhibitor of mTOR. These findings suggest that d-glucosamine can inhibit growth of cancer cells through dephosphorylation of p70S6K.
Keywords: d-Glucosamine; p70S6K; RPS6; Cell proliferation; Prostate cancer; Breast cancer
Article Outline
- Materials and methods
- Results
- d-Glucosamine inhibits cell proliferation of DU145 cells
- d-Glucosamine induces dephosphorylation of p70S6K and RPS6
- d-Glucosamine inhibits proliferation of MDA-MB-231 breast cancer cells
- d-Glucosamine enhances anticancer effect of rapamycin
- Discussion
- Acknowledgements
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (0)

80 and 




